Axonics SNM System for Bowel Control
7
Axonics SNM System for Bowel Control
Indications
Axonics SNM Therapy for bowel control is indicated for the treatment of chronic fecal incontinence in patients who
have failed or are not candidates for more conservative treatments.
Precautions
Clinician Training
Implanting clinicians
should be trained on the implantation and use of the Axonics SNM System.
Prescribing clinicians
should be experienced in the diagnosis and treatment of fecal incontinence and
should be trained on the use of the Axonics SNM System.
Use in Specific Populations
The safety and effectiveness of this therapy has not been established for:
Pregnant women
Pediatric use (patients under the age of 18)
Patients with progressive, systemic neurological diseases
Bilateral stimulation
Contraindications
The Axonics SNM System is contraindicated for the following patients
•
Patients who have not demonstrated an appropriate response to test stimulation; or
•
Patients who are unable to operate the Axonics SNM System.
